TherapeuticsMD, Inc. to Participate in Upcoming Investor Conferences

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women’s healthcare company, today announced CEO Robert G. Finizio will provide an overview of the company at the following investor conferences:

• Jefferies 2015 Global Healthcare Conference, Tuesday, June 2 at 10 a.m. EDT at the Grand Hyatt New York in New York City
• Goldman Sachs 36th Annual Global Healthcare Conference, Tuesday, June 9 at 9:20 a.m. PDT at the Terranea Resort in Rancho Palos Verdes, Calif.

To listen to the live audio webcasts during the sessions, please visit the company's website, www.therapeuticsmd.com, and click the “Investor” tab. Replays of each webcast will be available on the company’s website for 30 days after the respective sessions.

About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. is an innovative healthcare company focused on developing and commercializing products exclusively for women. With its patented SYMBODA™ technology, TherapeuticsMD is developing advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The company’s clinical development pipeline includes two phase 3 products. The company also manufactures and distributes branded and generic prescription prenatal vitamins as well as over-the-counter vitamins under the vitaMedMD® and BocaGreenMD® brands. More information is available at the following websites: www.therapeuticsmd.com, www.vitamedmd.com, www.vitamedmdrx.com and www.bocagreenmd.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150526005543/en/